Literature DB >> 32825930

FTO accelerates ovarian cancer cell growth by promoting proliferation, inhibiting apoptosis, and activating autophagy.

Lin Zhao1, Xianchao Kong1, Wen Zhong1, Yu Wang1, Peiling Li2.   

Abstract

OBJECTIVE: Fat mass and obesity-associated protein (FTO) is identified as a critical demethylase involved in various physiological processes. Despite efforts have been made to study the biological functions of FTO in certain cancers, the role of FTO in ovarian cancer is largely unknown. In this study, we sought to investigate the function of FTO on proliferation, apoptosis and autophagy of ovarian cancer cells.
METHODS: Quantitative real-time PCR was performed to detect FTO expression in ovarian tumor tissues and ovarian cancer cell lines OVCAR-3, SKOV-3, COC1, HO-8910 and A2780. SKOV-3 cells were constructed with FTO overexpression and A2780 cells were constructed with FTO knockdown. CCK-8 assay was used to examine cell viability and flow cytometry was used to detect cell apoptosis. Activity assay kits were applied to detect caspase-3 and caspase-9 levels. Western blot was performed to measure the expressions of FTO, PCNA, Bax, Bcl-2, LC3, ATG5, P62, p-AKT and AKT. Stable FTO-overexpression SKOV-3 cells or FTO-depletion A2780 cells were injected subcutaneously into male Balb/c-nu mice. Xenografted tumors were assayed by H&E staining. Immunohistochemistry was subjected to measure FTO and Ki67 expressions.
RESULTS: FTO was up-regulated in ovarian tumor tissues compared with non-cancerous ovarian tissues. FTO overexpression markedly increased viability and autophagy function, but decreased apoptosis of ovarian cancer cells. In addition, FTO overexpression promoted AKT phosphorylation. In contrast, FTO silence showed the opposite effect.
CONCLUSION: FTO accelerated ovarian cancer cell growth by promoting proliferation, inhibiting apoptosis, and activating autophagy.
Copyright © 2020 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Apoptosis; Autophagy; FTO; Ovarian cancer; Proliferation

Mesh:

Substances:

Year:  2020        PMID: 32825930     DOI: 10.1016/j.prp.2020.153042

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  11 in total

1.  FGF2 Is Protective Towards Cisplatin-Induced KGN Cell Toxicity by Promoting FTO Expression and Autophagy.

Authors:  Rongli Wang; Lijun Wang; Lihui Wang; Zhiwei Cui; Feiyan Cheng; Wei Wang; Xinyuan Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

Review 2.  Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application.

Authors:  Fusheng Zhang; Haiyang Liu; Meiqi Duan; Guang Wang; Zhenghou Zhang; Yutian Wang; Yiping Qian; Zhi Yang; Xiaofeng Jiang
Journal:  J Hematol Oncol       Date:  2022-07-06       Impact factor: 23.168

Review 3.  Effects of N6-Methyladenosine Modification on Cancer Progression: Molecular Mechanisms and Cancer Therapy.

Authors:  Yong-Fu Zhu; Shu-Jie Wang; Jie Zhou; Ye-Han Sun; You-Mou Chen; Jia Ma; Xing-Xing Huo; Hang Song
Journal:  Front Oncol       Date:  2022-05-30       Impact factor: 5.738

4.  Crosstalk of Histone and RNA Modifications Identified a Stromal-Activated Subtype with Poor Survival and Resistance to Immunotherapy in Gastric Cancer.

Authors:  Cheng Yuan; Junchang Zhang; Cuncan Deng; Yujian Xia; Bo Li; Sijun Meng; Xinghan Jin; Lvjia Cheng; Huafu Li; Changhua Zhang; Yulong He
Journal:  Front Pharmacol       Date:  2022-05-05       Impact factor: 5.988

5.  FTO Gene Polymorphisms Contribute to the Predisposition and Radiotherapy Efficiency of Nasopharyngeal Carcinoma.

Authors:  Feng Xiao; Jianrong Zhou
Journal:  Pharmgenomics Pers Med       Date:  2021-09-28

Review 6.  FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.

Authors:  Sarah Kassem Azzam; Habiba Alsafar; Abdulrahim A Sajini
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

7.  Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by modulating the expression of melanocortin 4 receptor (MC4R).

Authors:  Sheng Li; Lin Cao
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

8.  GSK3β Exacerbates Myocardial Ischemia/Reperfusion Injury by Inhibiting Myc.

Authors:  Cong Wen; Meide Lan; Xin Tan; Xiaobo Wang; Zaiyong Zheng; Mingming Lv; Xuemei Zhao; Hao Luo; Yanxu Liu; Ping Wei; Rongchuan Yue; Houxiang Hu; Li Guo
Journal:  Oxid Med Cell Longev       Date:  2022-04-29       Impact factor: 7.310

9.  Down-regulation of PSMD4 can attenuate autophagy, enhance the accumulation of intracellular ROS, and increase the sensitivity of epithelial ovarian cancer to carboplatin by inhibiting the NF-κB pathway.

Authors:  Ying Li; Qin Zhou; Jing Shen; Lixia Zhu
Journal:  Transl Cancer Res       Date:  2021-11       Impact factor: 1.241

10.  Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin.

Authors:  Yan Wang; Zhiqiang Cheng; Jing Xu; Meina Lai; Liming Liu; Min Zuo; Lin Dang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.